Critical appraisal of clinical guidelines for prevention and management of doxorubicin-induced cardiotoxicity

Loading...
Thumbnail Image

Date

2022

Journal Title

Journal ISSN

Volume Title

Publisher

Journal of Oncology Pharmacy Practice

Abstract

Objective: Doxorubicin is a valuable chemotherapeutic drug; however, it is associated with a high risk of cardiotoxicity. Several institutions and organizations have developed guidelines for risk factor assessment, monitoring, and prevention strategies against chemotherapy-induced cardiotoxicity. This review aimed to assess the quality of current practice guidelines, using the Appraisal of Guidelines for Research and Evaluation II (AGREE II). This tool was used to compare the recommendations with regards to their strength and the evidence recommendations were based on.

Description

Keywords

doxorubicin, assessment, monitoring, management, guideline

Citation

Moustafa, I., Viljoen, M., Perumal-Pillay, V. A., & Oosthuizen, F. (2022). Critical appraisal of clinical guidelines for prevention and management of doxorubicin-induced cardiotoxicity. Journal of Oncology Pharmacy Practice, 107815522211476. https://doi.org/10.1177/10781552221147660